Thursday's industry-shaking news that AquaBounty's AquAdvantage genetically modified salmon has earned US Food and Drug Administration (FDA) approval is the culmination of more than two decades of work by the Massachussets-based company and its executives.
Here are some key moments in the road to approval:
1989: GM salmon first developed at Memorial University of Newfoundland
1991: AquaBounty established as a company
1993: AquaBounty first seeks FDA approval for its trans-genic AquAdvantage salmon
Nov. 19, 2015:FDA approves AquAdvantage salmon